Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial ScienceDirect Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination How does CagriSema (Cagrilintide) Work? Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE 1 sub analysis, unveiled at EASD 2025 Pharmacally Cagrilintide: Effective Weekly Dosage and Weight Loss Benefits Explained Cagrilintide vs Retatrutide for Weight Loss and Metabolic Health BetteryouRx